{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:42:14Z","timestamp":1767980534821,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["DEC-2011\/03\/B\/NZ7\/01999"],"award-info":[{"award-number":["DEC-2011\/03\/B\/NZ7\/01999"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.bbr.2015.03.053","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T04:15:19Z","timestamp":1428207319000},"page":"135-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Study of antidepressant drugs in GPR39 (zinc receptor\u2212\/\u2212) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-8154","authenticated-orcid":false,"given":"Katarzyna","family":"M\u0142yniec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Gawe\u0142","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2015.03.053_bib0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.053_bib0135","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","article-title":"Glutamate-based antidepressants: preclinical psychopharmacology","volume":"73","author":"Pilc","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.053_bib0140","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1300.016","article-title":"Glutamate and depression: clinical and preclinical studies","volume":"1003","author":"Paul","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbr.2015.03.053_bib0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-3223(96)00365-4","article-title":"Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune\/inflammatory response in that illness","volume":"42","author":"Maes","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.053_bib0150","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.neubiorev.2013.03.018","article-title":"Potential roles of zinc in the pathophysiology and treatment of major depressive disorder","volume":"37","author":"Swardfager","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2015.03.053_bib0155","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S1734-1140(13)71512-3","article-title":"Zinc as a marker of affective disorders","volume":"65","author":"Siwek","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.bbr.2015.03.053_bib0160","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1210\/en.2006-0933","article-title":"GPR39 signaling is stimulated by zinc ions but not by obestatin","volume":"148","author":"Holst","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2015.03.053_bib0165","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/01.wnr.0000215779.76602.93","article-title":"GPR39 receptor expression in the mouse brain","volume":"17","author":"Jackson","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2015.03.053_bib0170","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1523\/JNEUROSCI.5093-08.2009","article-title":"Synaptically released zinc triggers metabotropic signaling via a zinc-sensing receptor in the hippocampus","volume":"29","author":"Besser","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.03.053_bib0175","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nm0502-450","article-title":"CREB family transcription factors inhibit neuronal suicide","volume":"8","author":"Dawson","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.bbr.2015.03.053_bib0180","first-page":"89","article-title":"GPR39 Zn(2+)-sensing receptor: a new target in antidepressant development?","volume":"174C","author":"M\u0142yniec","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2015.03.053_bib0185","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2013.12.001","article-title":"The involvement of the GPR39-Zn(2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims","volume":"79","author":"M\u0142yniec","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2015.03.053_bib0190","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.neuint.2013.02.024","article-title":"GPR39 up-regulation after selective antidepressants","volume":"62","author":"M\u0142yniec","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.bbr.2015.03.053_bib0195","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1210\/en.2008-1250","article-title":"G protein-coupled receptor 39 deficiency is associated with pancreatic islet dysfunction","volume":"150","author":"Holst","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbr.2015.03.053_bib0200","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-0327(99)00011-7","article-title":"Lower serum zinc in major depression in relation to changes in serum acute phase proteins","volume":"56","author":"Maes","year":"1999","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2015.03.053_bib0205","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.biopsych.2013.05.008","article-title":"Zinc in depression: a meta-analysis","volume":"74","author":"Swardfager","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.053_bib0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bbr.2012.10.020","article-title":"The role of the GPR39 receptor in zinc deficient-animal model of depression","volume":"238","author":"M\u0142yniec","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.053_bib0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jad.2009.02.014","article-title":"Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study","volume":"118","author":"Siwek","year":"2009","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbr.2015.03.053_bib0220","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.pnpbp.2008.09.006","article-title":"Interaction of zinc with antidepressants in the tail suspension test","volume":"32","author":"Cunha","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.053_bib0225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pnpbp.2008.12.011","article-title":"The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test","volume":"33","author":"Szewczyk","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2015.03.053_bib0230","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.1523\/JNEUROSCI.0237-13.2013","article-title":"Synaptic Zn2+ inhibits neurotransmitter release by promoting endocannabinoid synthesis","volume":"33","author":"Perez-Rosello","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.03.053_bib0235","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1523\/JNEUROSCI.2205-11.2011","article-title":"Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR\/GPR39 receptor","volume":"31","author":"Chorin","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2015.03.053_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu002","article-title":"GPR39 (zinc receptor) knockout mice exhibit depression-like behavior and CREB\/BDNF down-regulation in the hippocampus","volume":"18","author":"M\u0142yniec","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2015.03.053_bib0245","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2015.01.018","article-title":"Antidepressant dose of taurine increases mRNA expression of GABAA receptor \u03b12 subunit and BDNF in the hippocampus of diabetic rats","volume":"283C","author":"Caletti","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2015.03.053_bib0250","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuropharm.2011.08.015","article-title":"The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf+\/\u2212 heterozygous null mice","volume":"62","author":"Lindholm","year":"2012","journal-title":"Neuropharmacology"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815002181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432815002181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T19:27:28Z","timestamp":1566502048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432815002181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":25,"alternative-id":["S0166432815002181"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2015.03.053","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of antidepressant drugs in GPR39 (zinc receptor\u2212\/\u2212) knockout mice, showing no effect of conventional antidepressants, but effectiveness of NMDA antagonists","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2015.03.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}